Core Viewpoint - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have issued a notice regarding the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" initiative, adding 27 new hospitals while removing one [1] Group 1: Designated Medical Institutions - The new designated hospitals include 27 medical institutions such as the Southern Medical University Zhujiang Hospital, while the Foshan Ximalin Shunchao Eye Hospital has been removed from the list [1] - The application process for the fourth batch of designated medical institutions began in August, with a review of the qualifications of the previous three batches [1] - A total of 44 hospitals passed the qualification review, and the current total of designated medical institutions has reached 71 [1] Group 2: Regulatory and Operational Requirements - The notice mandates that relevant municipal administrative departments enhance supervision and management of designated medical institutions [1] - Designated medical institutions are required to deepen cooperation with Hong Kong and Macao in medical services, clinical research, and the importation of medical devices and drugs [1] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in medication and equipment [1] Group 3: Historical Context and Impact - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in Guangdong Province in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [1] - A total of 140 varieties of drugs and medical devices (63 drugs and 77 devices) have been approved for import and use, benefiting approximately 17,000 patients [1]

Core Points - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have released the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" policy, bringing the total to 71 institutions [1] - A total of 140 types of Hong Kong and Macao drugs and medical devices have been approved for use, benefiting approximately 17,000 patients [1] - The policy allows designated medical institutions in the Greater Bay Area to use urgently needed drugs and advanced medical devices that have been approved in Hong Kong and Macao [1] Group 1 - The fourth batch of designated medical institutions includes 27 new hospitals, with 44 hospitals passing the qualification review, and one hospital removed due to closure [1] - Notable new hospitals include Southern Medical University Zhujiang Hospital, Guangzhou Medical University Affiliated Brain Hospital, and Guangdong Second People's Hospital [1] - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [2] Group 2 - Local administrative departments are required to strengthen supervision and management of designated medical institutions [2] - Designated institutions are encouraged to deepen cooperation with Hong Kong and Macao in medical services and clinical research [2] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in their use [2]

Core Points - The "Hong Kong-Macao Drug and Medical Device Pass" has designated a total of 71 medical institutions in Guangdong Province as of December 8, 2023 [1][2] - The fourth batch of designated hospitals includes 27 new medical institutions, such as the Southern Medical University Zhujiang Hospital [1] - Since the implementation of the "Hong Kong-Macao Drug and Medical Device Pass" in 2021, a total of 140 varieties of drugs and medical devices have been approved for import, benefiting approximately 17,000 patients [2] Summary by Sections Implementation and Designation - The "Hong Kong-Macao Drug and Medical Device Pass" was officially implemented in Guangdong Province in 2021, with the first three batches of designated medical institutions announced in August 2021, February 2023, and September 2024 [2] - The recent announcement includes 27 new hospitals, bringing the total to 71 designated institutions [1][2] Regulatory and Operational Aspects - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have mandated that designated medical institutions enhance supervision and management, deepen cooperation with Hong Kong and Macao in medical services, and ensure the safety of imported drugs and medical devices [1] - The institutions are required to continuously improve the relevant systems of the "Hong Kong-Macao Drug and Medical Device Pass" [1] Patient Impact - The approved imports include 63 types of drugs and 77 types of medical devices, which have collectively served around 17,000 patients [2]